Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1 × Aggression × Dexamethasone × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Multiple Myeloma 113 Recurrence 23 Precursor Cell Lymphoblastic Leukemia-Lymphoma 19 Neoplasms, Plasma Cell 13 Neoplasms 12 Lymphoma, Non-Hodgkin 10 Lymphoma 10 Leukemia, Myeloid, Acute 9 Neoplasm Metastasis 8 Leukemia 8 Lymphoma, Large B-Cell, Diffuse 6 Burkitt Lymphoma 6 Prostatic Neoplasms 5 Hodgkin Disease 5 Leukemia, Biphenotypic, Acute 4 Immunoglobulin Light-chain Amyloidosis 4 Waldenstrom Macroglobulinemia 3 Lymphoma, T-Cell, Peripheral 3 Lymphoma, T-Cell, Cutaneous 3 Lymphoma, T-Cell 3 Lymphoma, B-Cell 3 Leukemia, Lymphocytic, Chronic, B-Cell 3 Colorectal Neoplasms 3 Unspecified Adult Solid Tumor, Protocol Specific 2 Sarcoma 2 Rectal Neoplasms 2 Plasmacytoma 2 Paraproteinemias 2 Oligodendroglioma 2 Myelodysplastic Syndromes 2

Interventions

selinexor 1 Rituximab 1 Ifosfamide 1 Etoposide 1 Dexamethasone 1 Carboplatin 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT02471911 2022-04-12

KPT-330+RICE

Weill Medical College of Cornell University

Phase 1 Completed

Aggression, Lymphoma, Large B-Cell, Diffuse

Data powered by HemOnc (CC BY 4.0) Colophon ⚡